Home About Us Pipeline News Investors Contacts Careers


News

Recent Press Releases Archives

Recent Press Releases

2012 News Releases

December 7, 2012 - Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium

Phase II Results Demonstrate Efficacy of PB272 in Combination with Temsirolimus in HER2+ Metastatic Breast Cancer
Read

Nov. 14, 2012 - Puma Biotechnology Reports Third Quarter 2012 Financial Results
Read

Nov. 7, 2012 - Puma Biotechnology to Present at Lazard Healthcare Conference
Read

October 24, 2012 - Puma Biotechnology Closes $138 Million Public Offering of Common Stock
Read

October 22, 2012 - Puma Biotechnology Announces Underwriters' Full Exercise of Overallotment Option, Increasing Total Offering Size to $138 Million
Read

October 18, 2012 - Puma Biotechnology Announces Upsizing and Pricing of $120 Million Public Offering of Common Stock
Read

September 12, 2012 - Puma Biotechnology to Present at UBS Global Life Sciences Conference
Read

August 29, 2012 - Puma Biotechnology to Present at Stifel Nicolaus 2012 Healthcare Conference
Read

August 14, 2012 - Puma Biotechnology Reports Second Quarter 2012 Financial Results
Read


August 7, 2012 - Puma Biotechnology to Present at Wedbush PacGrow Life Sciences Conference
Read


June 2, 2012 - Puma Biotechnology Presents Positive PB272 Clinical Data at ASCO 2012 Annual Meeting

Phase I Results Demonstrate Safety and Efficacy of PB272 in Combination with Paclitaxel and Trastuzumab in Women with Metastatic HER-2 Positive Breast Cancer
Read


May 30, 2012 - Puma Biotechnology to Present at Jefferies Healthcare Conference
Read


May 17, 2012 - Puma Biotechnology to Present Clinical Data on PB272 at ASCO 2012 Annual Meeting
Read


May 9, 2012 - Puma - Merrill Lynch Health Care Conference
Read


April 16, 2012 - Puma Biotechnology Cleared for Quotation on OTCBB and OTC LINK
Read


February 28, 2012 - Puma Biotechnology to Present at Cowen Health Care Conference
Read


February 9, 2012 - Puma Biotechnology to Present at Leerink Swann Global Healthcare Conference
Read


January 4, 2012 - Puma Biotechnology to Present at 30th Annual J.P. Morgan Healthcare Conference
Read



Corporate Fact Sheet

Puma Biotechnology, Inc.

10880 Wilshire Blvd., Suite 2150
Los Angeles, CA 90024
424-248-6500 Main
424-248-6501 Fax

info@pumabiotechnology.com